10 min read
Ageing & Epigenetic Research Peptides
Preclinical research on telomerase activation, mitochondrial function, and epigenetic peptide mechanisms.
The Biology of Aging
Aging is associated with several interconnected mechanisms: telomere shortening, mitochondrial dysfunction, accumulation of senescent cells, epigenetic drift, and declining stem cell function. Modern longevity research investigates these mechanisms at the molecular level. Peptides are of particular interest because they can modulate specific signalling pathways, and several are actively studied in preclinical aging models.
Epithalon and Telomerase
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland peptide epithalamin. Its primary research interest is the activation of telomerase — the enzyme that extends telomeres, the protective caps at the end of chromosomes. In cell culture studies, epithalon has been shown to reactivate telomerase in human somatic cells, extending their replicative lifespan. Russian research by Vladimir Khavinson reported increased lifespan in animal models, though these results await independent replication in Western laboratories.
GHK-Cu and Gene Expression
GHK-Cu is increasingly studied in the longevity context because of its effect on gene expression. Research by Loren Pickart demonstrated that GHK-Cu modulates the activity of over 4,000 human genes, with a net effect of shifting gene expression toward patterns associated with younger tissue samples. Genes upregulated include those involved in DNA repair, antioxidant defence, collagen synthesis, and stem cell maintenance. Genes downregulated include those associated with inflammation and tissue degradation.
Growth Hormone Secretagogues and Aging
Growth hormone production declines approximately 14% per decade after age 30 — a phenomenon termed somatopause in the endocrinology literature. This decline correlates with changes in body composition, skin thickness, and immune markers in observational studies. GH secretagogues like Ipamorelin and CJC-1295 stimulate the pituitary to release GH in a more physiological, pulsatile pattern. The research interest centres on whether secretagogue-stimulated release preserves natural feedback mechanisms compared to exogenous GH administration.
The Integrated Approach
Longevity research increasingly examines multi-compound approaches. Published preclinical frameworks have investigated: Epithalon (telomere maintenance), GHK-Cu (gene expression and ECM remodelling), and GH secretagogues (pituitary GH release). This multi-pathway approach reflects the understanding that aging involves a convergence of multiple degenerative mechanisms, each of which is studied independently in the research literature.
Research Disclaimer: All content on this page is provided for educational and informational purposes only and relates strictly to published preclinical research. Silver Peptide products are supplied for in vitro laboratory research use only. They are not approved by the MHRA, FDA, or any regulatory body for human consumption, injection, or veterinary use. They are not medicines and must not be used as such. Nothing on this page constitutes medical advice.